Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer

被引:4
|
作者
Zhao, Hanqing [1 ]
Huang, Ying [1 ]
Tong, Guoshun [1 ]
Wu, Wei [1 ]
Ren, Yangwu [1 ]
机构
[1] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110122, Peoples R China
基金
中国国家自然科学基金;
关键词
oxidative stress; anoikis; NSCLC; TME; immune landscape; stemness; MECHANISMS;
D O I
10.3390/ijms242216188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to identify a kind of prognostic signature based on oxidative stress- and anoikis-related genes (OARGs) for predicting the prognosis and immune landscape of NSCLC. Initially, We identified 47 differentially expressed OARGs that primarily regulate oxidative stress and epithelial cell infiltration through the PI3K-Akt pathway. Subsequently, 10 OARGs related to prognosis determined two potential clusters. A cluster was associated with a shorter survival level, lower immune infiltration, higher stemness index and tumor mutation burden. Next, The best risk score model constructed by prognostic OARGs was the Random Survival Forest model, and it included SLC2A1, LDHA and PLAU. The high-risk group was associated with cluster A and poor prognosis, with a higher tumor mutation burden, stemness index and proportion of M0-type macrophages, and a lower immune checkpoint expression level, immune function score and IPS score. The calibration curve and decision-making curve showed that the risk score combined with clinical pathological characteristics could be used to construct a nomogram for guiding the clinical treatment strategies. Finally, We found that all three hub genes were highly expressed in tumor tissues, and LDHA expression was mainly regulated by has-miR-338-3p, has-miR-330-5p and has-miR-34c-5p. Altogether, We constructed an OARG-related prognostic signature to reveal potential relationships between the signature and clinical characteristics, TME, stemness, tumor mutational burden, drug sensitivity and immune landscape in NSCLC patients.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] Identification and functional analysis of novel Non-Small Cell Lung Cancer related genes
    Hosono, Yasuyuki
    CANCER SCIENCE, 2018, 109 : 363 - 363
  • [22] A Novel Prognostic Transcriptional Signature for Early Stage Non-small Cell Lung Cancer
    Ruiz, J.
    Miller, A. A.
    Petty, W. J.
    Chou, J. W.
    Miller, L. D.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S505 - S505
  • [23] A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs
    Zhang, Miao
    Zuo, Yuzhi
    Guo, Jian
    Yang, Lushan
    Wang, Yizhi
    Tan, Meiyun
    Guo, Xing
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs
    Miao Zhang
    Yuzhi Zuo
    Jian Guo
    Lushan Yang
    Yizhi Wang
    Meiyun Tan
    Xing Guo
    Scientific Reports, 13
  • [25] Validation of endoplasmic reticulum stress-related gene signature to predict prognosis and immune landscape of patients with non-small cell lung cancer
    Cui, Yingying
    Zhou, Xiaoli
    Zheng, Dan
    Zhu, Yumei
    TECHNOLOGY AND HEALTH CARE, 2025, 33 (01) : 363 - 393
  • [26] Prognostic Immune Markers in Non-Small Cell Lung Cancer
    Suzuki, Kei
    Kachala, Stefan S.
    Kadota, Kyuichi
    Shen, Ronglai
    Mo, Qianxing
    Beer, David G.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5247 - 5256
  • [27] Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data
    Wang, Yifan
    Wang, Ying
    Zhang, Yongjun
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma
    Qin, Haotian
    Wang, Qichang
    Xu, Juan
    Zeng, Hui
    Liu, Jixian
    Yu, Fei
    Yang, Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [29] Development of oxidative stress- and ferroptosis-related prognostic signature in gastric cancer and identification of CDH19 as a novel biomarker
    Wang, Shibo
    Zhang, Siyi
    Li, Xiaoxuan
    Leng, Chuanyu
    Li, Xiangxue
    Lv, Jing
    Zhao, Shufen
    Qiu, Wensheng
    Guo, Jing
    HUMAN GENOMICS, 2024, 18 (01)
  • [30] Telomere length-related signature as a novel biomarker of prognosis and immune response in non-small cell lung cancer
    Liu, X-G
    Li, M.
    Mai, S-J
    Cai, R-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (04) : 1304 - 1319